A Brave New World.
作者信息
Wang Kang-Ling, Chiang Chern-En
机构信息
General Clinical Research Center, Taipei Veterans General Hospital.
School of Medicine, National Yang-Ming University, Taipei, Taiwan.
出版信息
Acta Cardiol Sin. 2019 Sep;35(5):522-523. doi: 10.6515/ACS.201909_35(5).20190906A.
Abstract
摘要
相似文献
1
A Brave New World.一个美丽新世界。
Acta Cardiol Sin. 2019 Sep;35(5):522-523. doi: 10.6515/ACS.201909_35(5).20190906A.
2
The Use and Misuse of in the CRISPR Debate.在 CRISPR 争论中对“编辑”的使用和滥用。
CRISPR J. 2019 Oct;2(5):316-323. doi: 10.1089/crispr.2019.0046.
3
Brave new baby in the brave new world.这个全新世界里的全新婴儿。
Women Health. 1987;13(1-2):149-53. doi: 10.1300/j013v13n01_13.
4
"No Country for Old Men": Huxley's Brave New World and the Value of Old Age.《老人无国》：赫胥黎的《美丽新世界》与老年的价值
J Med Humanit. 2019 Sep;40(3):395-415. doi: 10.1007/s10912-017-9469-x.
5
Brave new world revisited revisited: Huxley's evolving view of behaviorism.《重访<美丽新世界>：赫胥黎对行为主义不断演变的看法》
Behav Anal. 1992 Spring;15(1):61-9. doi: 10.1007/BF03392586.
6
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).两项 III 期临床试验（BRAVE-AA1 和 BRAVE-AA2）中连续治疗 52 周时巴瑞替尼治疗严重斑秃患者的疗效和安全性。
Am J Clin Dermatol. 2023 May;24(3):443-451. doi: 10.1007/s40257-023-00764-w. Epub 2023 Mar 1.
7
Designing a brave new world: eugenics, politics, and fiction.设计一个勇敢的新世界：优生学、政治与小说。
Public Hist. 2007 Summer;29(3):105-29. doi: 10.1525/tph.2007.29.3.105.
8
'E' therapy in the community: Examination of the uptake and effectiveness of BRAVE (a self-help computer programme for anxiety in children and adolescents) in primary care.社区中的“E”疗法：对初级保健中BRAVE（一款针对儿童和青少年焦虑症的自助计算机程序）的采用情况及效果的考察。
Internet Interv. 2019 May 3;18:100249. doi: 10.1016/j.invent.2019.100249. eCollection 2019 Dec.
9
Two Phase 3 Trials of Baricitinib for Alopecia Areata.两项关于巴瑞替尼治疗斑秃的3期试验。
N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26.
10
Text Messaging Intervention for Mental Wellness in American Indian and Alaska Native Teens and Young Adults (BRAVE Study): Analysis of User Engagement Patterns.美国印第安和阿拉斯加原住民青少年及青年心理健康的短信干预（勇敢研究）：用户参与模式分析
JMIR Form Res. 2022 Feb 25;6(2):e32138. doi: 10.2196/32138.
本文引用的文献
1
Comparative Effectiveness and Safety of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome or Percutaneous Coronary Intervention.急性冠状动脉综合征或经皮冠状动脉介入治疗的心房颤动患者抗血栓治疗的比较有效性和安全性
Acta Cardiol Sin. 2019 Sep;35(5):508-521. doi: 10.6515/ACS.201909_35(5).20190311A.
2
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.依度沙班与维生素 K 拮抗剂在房颤患者成功经皮冠状动脉介入治疗后抗栓治疗方案的比较（ENTRUST-AF PCI）：一项随机、开放标签、3b 期临床试验。
Lancet. 2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3.
3
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.心房颤动合并稳定性冠心病的抗栓治疗。
N Engl J Med. 2019 Sep 19;381(12):1103-1113. doi: 10.1056/NEJMoa1904143. Epub 2019 Sep 2.
4
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.心房颤动急性冠状动脉综合征或经皮冠状动脉介入治疗后的抗血栓治疗。
N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.
5
2018 Expert Consensus on the Management of Adverse Effects of Antiplatelet Therapy for Acute Coronary Syndrome in Taiwan.《2018年台湾急性冠状动脉综合征抗血小板治疗不良反应管理专家共识》
Acta Cardiol Sin. 2018 May;34(3):201-210. doi: 10.6515/ACS.201805_34(3).20180302A.
6
The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.急性冠状动脉综合征的管理与预后因素：来自台湾急性冠状动脉综合征全谱注册研究的证据
Acta Cardiol Sin. 2017 Jul;33(4):329-338. doi: 10.6515/acs20161205a.
7
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.房颤患者 PCI 术后的达比加群双重抗血栓治疗。
N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.
8
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.经皮冠状动脉介入治疗（PCI）的房颤患者的出血预防。
N Engl J Med. 2016 Dec 22;375(25):2423-2434. doi: 10.1056/NEJMoa1611594. Epub 2016 Nov 14.
9
2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.台湾心律学会与台湾心脏病学会2016年心房颤动管理指南。
J Formos Med Assoc. 2016 Nov;115(11):893-952. doi: 10.1016/j.jfma.2016.10.005. Epub 2016 Nov 24.
10
Complexity of atrial fibrillation patients and management in Chinese ethnicity in routine daily practice: insights from the RealiseAF Taiwanese cohort.日常实践中中国台湾地区房颤患者的复杂性及管理：来自RealiseAF台湾队列的见解
J Cardiol. 2014 Sep;64(3):211-7. doi: 10.1016/j.jjcc.2014.01.010. Epub 2014 Mar 3.
Zotero 插件